12:02 PM EST - PreMD Inc. : lost more than 71 percent of its stock value on Tuesday after the U.S. Food and Drug Administration rejected its regulatory claim submission for its point-of-care skin cholesterol test. PreMD Inc.
shares T.PMD are trading off 93 cents at $0.37.
